Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin

doi:10.4251/wjgo.v15.i2.286

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2970)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-3) series.

Item

Count

PDF

104

WORD

HTML

1019

Figures (1-8)

197

Tables (1-3)

149

Sum=1500

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

264

Download

666

Sum=930

Publishing Process of This Article

Item

Count

Browse

143

Download

397

Sum=540

Feb 15, 2023 (publication date) through Jul 16, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Feb 15, 2023; 15(2): 286-302
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.286

Table 2 Univariate and multivariate analyses of overall survival in patients with gastric cancer

Prognostic variables	Univariate analysis			Multivariate analysis
Prognostic variables	Hazard ratio	95% confidence interval	P value	Hazard ratio	95% confidence interval	P value
Sex	0.99	0.584–1.679	0.97	-	-	-
Age	1.372	0.820–2.296	0.229	-	-	-
Tumor location	0.925	0.545–1.569	0.772	-	-	-
Histological grade	0.736	0.420–1.288	0.283	-	-	-
Tumor size	2.417	1.399–4.176	0.004^a	0.87	0.504–1.504	0.619
T stage	3.184	1.687–6.007	0.000^a	2.651	1.295–5.423	0.008^a
N stage	2.034	1.196–3.457	0.009^a	1.414	0.709–2.818	0.325
TNM stage	1.946	1.168–3.243	0.011^a	0.912	0.469–1.774	0.786
CIP2A expression	2.319	1.288–3.927	0.003^a	1. 802	1.012–3.210	0.046^a

^aP < 0.05.

T: Tumor; N: Node; TNM: Tumor Node Metastasis; CIP2A: Cancerous inhibitor of protein phosphatase 2A.

Citation: Zhao YX, Ma LB, Yang Z, Wang F, Wang HY, Dang JY. Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin. World J Gastrointest Oncol 2023; 15(2): 286-302
URL: https://www.wjgnet.com/1948-5204/full/v15/i2/286.htm
DOI: https://dx.doi.org/10.4251/wjgo.v15.i2.286